- Home
- PFLT vs MLAB Comparison
PFLT vs MLAB Comparison
Compare PFLT & MLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PFLT
- MLAB
- Stock Information
- Founded
- PFLT 2010
- MLAB 1982
- Country
- PFLT United States
- MLAB United States
- Employees
- PFLT N/A
- MLAB N/A
- Industry
- PFLT Finance: Consumer Services
- MLAB Industrial Machinery/Components
- Sector
- PFLT Finance
- MLAB Industrials
- Exchange
- PFLT Nasdaq
- MLAB Nasdaq
- Market Cap
- PFLT 808.2M
- MLAB 680.0M
- IPO Year
- PFLT N/A
- MLAB N/A
- Fundamental
- Price
- PFLT $10.17
- MLAB $125.02
- Analyst Decision
- PFLT Buy
- MLAB Hold
- Analyst Count
- PFLT 4
- MLAB 2
- Target Price
- PFLT $11.38
- MLAB $140.00
- AVG Volume (30 Days)
- PFLT 928.9K
- MLAB 39.1K
- Earning Date
- PFLT 05-12-2025
- MLAB 05-30-2025
- Dividend Yield
- PFLT 12.20%
- MLAB 0.50%
- EPS Growth
- PFLT 16.92
- MLAB N/A
- EPS
- PFLT 1.37
- MLAB N/A
- Revenue
- PFLT $215,391,000.00
- MLAB $237,747,000.00
- Revenue This Year
- PFLT $48.14
- MLAB $13.48
- Revenue Next Year
- PFLT $9.03
- MLAB $4.74
- P/E Ratio
- PFLT $7.37
- MLAB N/A
- Revenue Growth
- PFLT 47.56
- MLAB 11.68
- 52 Week Low
- PFLT $8.82
- MLAB $83.68
- 52 Week High
- PFLT $12.02
- MLAB $155.12
- Technical
- Relative Strength Index (RSI)
- PFLT 50.51
- MLAB 61.72
- Support Level
- PFLT $9.98
- MLAB $116.81
- Resistance Level
- PFLT $10.18
- MLAB $120.05
- Average True Range (ATR)
- PFLT 0.17
- MLAB 4.04
- MACD
- PFLT 0.07
- MLAB 1.53
- Stochastic Oscillator
- PFLT 89.10
- MLAB 100.00
About PFLT PennantPark Floating Rate Capital Ltd.
PennantPark Floating Rate Capital Ltd is a closed-end, externally managed, non-diversified investment company. Its investment objectives are to generate current income and capital appreciation by investing in Floating Rate Loans and other investments made to U.S. middle-market companies. The company believes that Floating Rate Loans to U.S. middle-market companies offer attractive risk-reward to investors due to the limited amount of capital available for such companies and the potential for rising interest rates. The company generate revenue in the form of interest income on the debt securities and dividends.
About MLAB Mesa Laboratories Inc.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in 4 divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.